Psoriatic Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who currently have a high level of fatigue, scoring 60 or above on a specific fatigue scale (a 0–100 scale)
- People who have been experiencing fatigue as a significant problem for at least the past 3 months
- People who have been diagnosed with Rheumatoid Arthritis, Psoriatic Arthritis, or Spondyloarthritis, confirmed by a rheumatologist
- People whose condition is currently stable — meaning no changes have been made to their medications (including DMARDs, steroids, or steroid injections) in the last 3 months, and no changes are currently planned
- People who are registered as patients at the Danish Hospital of Rheumatic Diseases or Skaane University Hospital in Lund
- People aged 18 or older
- People who can speak and write Danish or Swedish well enough to take part in group discussions without needing an interpreter
- People who are willing to actively participate and make changes to their daily life as part of the program
Who may not be able to join:
- People who are pregnant or breastfeeding
- People with a serious illness that significantly affects life expectancy or organ function, such as certain cancers, severe heart failure, severe kidney failure, or severe anaemia (confirm with trial site)
- People with diabetes or thyroid disease that is not well-managed or controlled (confirm with trial site)
- People with an unstable mental health condition, dementia, or other significant cognitive difficulties
- People with hearing loss or hearing aids, where participation in a group setting may be affected (the trial site would need to assess this individually)
- People with any other physical or mental health condition that would make group participation unsuitable or prevent them from giving informed consent
- People whose fatigue is believed to be primarily caused by long-term effects of COVID-19 or Chronic Fatigue Syndrome
- People who are already taking part in another research project that could affect fatigue levels (specifically the WORK-ON, INSELMA, or SPINCODE studies)
- People who are already receiving support through a fatigue-specific program, either in hospital or elsewhere
- People who have a planned rehabilitation stay or another fatigue-focused program scheduled during the trial period
- People who are unable to commit to attending all scheduled sessions in one of the two trial programs
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jette Primdahl, Professor, The Danish Center for Expertise in Rheumatology
Phone: 0045 7365 4094
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Fatigue - the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ); Fatigue - the Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF-NRS v2)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.